Skip to main content
. 2020 Jun 5;14(11):E582–E587. doi: 10.5489/cuaj.6413

Table 2.

Best objective response of first-line agents in each group

High SII Low SII Total
No. of patients (n=64) (n=88) (n=152)
CR/PR 8 (12.5) 23 (26.1) 31 (20.4)
SD 40 (62.5) 58 (65.9) 98 (64.5)
PD 16 (25.0) 7 (8.0) 23 (15.1)

CR: complete response; PD: progressive disease; PR: partial response; SD: stable disease; SII: systemic immune inflammation index.